RECENT NEWS
Business Standard  10 hrs ago  Comment 
XCyton Diagnostics, a Bangalore-based molecular diagnostics products company, is developing two DNA macrochips for respiratory illness in the aged and a multi-drug resistant chip. A macrochip screens many disease agents at one go.
New York Times  Nov 5  Comment 
On-Q-ity, a new cancer diagnostics business, announced that it has raised $21 million in venture capital.
Marketwire  Nov 5  Comment 
SUNNYVALE, CA -- (Marketwire) -- 11/05/09 -- Arrayit Corporation (OTCBB: ARYC) is pleased to join the federal government in their efforts to help control health care costs through early diagnosis of diseases. For more than 150 years, traditional
Business Wire  Nov 4  Comment 
Biomagnetics Diagnostics Corp., (PINK SHEETS: BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has submitted an application to the Bill & Melinda Gates
Times Online  Nov 4  Comment 
Shares in Akers Biosciences slumped by more than 25 per cent yesterday after the diagnostics group said that its full-year results would be substantially below market expectations.
ABRN  Nov 4  Comment 
SPX is hosting a free one hour Webinar next week to help technicians improve their diagnostics skills. The Webinar will cover the Pegisys, graphing, bidirectional control, Mode 6, Direct Hit and scope usage. The Webinar is Nov. 9 at 6:30...
PR Newswire  Nov 2  Comment 
PLYMOUTH MEETING, Pa., Nov. 2 /PRNewswire/ -- BioBehavioral Diagnostics Company announced today that its poster was presented Friday, October 30, 2009 after it was accepted via a rigorous peer-review process and included as a New Research Poster
PR Newswire  Oct 27  Comment 
MURRIETA, Calif., Oct. 27 /PRNewswire/ -- Preparing for this flu season, the American Society for Microbiology (ASM) PSAB Committee on Laboratory Practices has recently published a new interim algorithm providing guidance to clinical laboratories
Business Wire  Oct 27  Comment 
Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company has completed business negotiations with one of the
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
 
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki